Table 4.
Univariable Liner Regression Analysis of CPET Values.
| VE/VCO2 slope | ||||
|---|---|---|---|---|
| Variables | R2 | Adjusted R2 | F-value | Standardized β |
| DGLA+AA | 0.13 | 0.12 | 7.26** | -0.37** |
| AA | 0.12 | 0.10 | 6.53* | -0.35* |
| DGLA | 0.08 | 0.06 | 3.83 | -0.27 |
| EPA+DHA | 0.006 | -0.01 | 0.29 | -0.07 |
| EPA | 0.01 | -0.01 | 0.47 | -0.10 |
| DHA | 0.003 | 0.02 | 0.16 | 0.69 |
| NT-proBNP | 0.12 | 0.10 | 6.44* | 0.35* |
| Alb | 0.08 | 0.06 | 4.20* | -0.29* |
| HbA1c | 0.03 | 0.01 | 1.62 | 0.18 |
| Peak VO2 | ||||
| Variables | R2 | Adjusted R2 | F-value | Standardized β |
| Alb | 0.12 | 0.10 | 6.71* | 0.35* |
| AA | 0.084 | 0.06 | 4.40* | 0.29* |
| DGLA+AA | 0.06 | 0.04 | 3.19 | 0.25 |
| DGLA | 0.04 | 0.02 | 2.08 | 0.20 |
| EPA+DHA | 0.006 | -0.01 | 0.29 | 0.08 |
| EPA | 0.022 | 0.002 | 1.01 | 0.15 |
| DHA | 0.0006 | -0.02 | 0.03 | 0.02 |
*p<0.05, **p<0.01
DGLA: dihomo-γ-linolenic acid, AA: arachidonic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, NT-pro BNP: N-terminal pro-brain natriuretic peptide, HbA1c: hemoglobin A1c, Alb: albumen, CPET: cardiopulmonary exercise test, peak VO2: peak oxygen uptake, VE/VCO2 slope: regression slope relating minute ventilation to carbon dioxide output